ADHD and Car Crashes; New Guidance on Stimulant Use Disorder Tx; KarXT Heads to FDA News and commentary from the psychiatry world Oct 04, 2023
Low Relapse Rates With Twice-Yearly Schizophrenia Treatment Every-6-month dosing of paliperidone palmitate was effective and safe up to 3 years Oct 03, 2023 video
Early Win for PTSD Drug; FDA OKs AI Sleep Diagnostic; Extreme Social Isolation Tool News and commentary from the psychiatry world Sep 27, 2023
Schizophrenia Sexual Dysfunction; Nuplazid Box Warning Tweak; Psych Practice Fraud? News and commentary from the psychiatry world Sep 20, 2023
Could This Neuroleptic Ward Off RA? Retrospective data suggest a preventive effect for old-line antipsychotic drug Sep 13, 2023
Safety Profile Sways Physicians on Use of LAIs for Schizophrenia Nearly half of hesitant prescribers cited safety and tolerability as their top concern Sep 12, 2023
Long-Acting Schizophrenia Tx Shows Long-Term Safety With Limited Relapses Most patients on twice-a-year doses of paliperidone palmitate remained relapse-free over 3 years Sep 11, 2023
Schizophrenia Deadlier in Heat? SSRI Brain Changes; Antipsychotic Finger Sweat Test News and commentary from the psychiatry world Sep 06, 2023
Social Anxiety Nasal Spray Win; Racemic Ketamine vs Esketamine; Is AI Pro-Anorexia? News and commentary from the psychiatry world Aug 09, 2023
MDMA Cured Extremism? Abilify Pain Cream Scheme; Ritalin's Opposite Effect in Some News and commentary from the psychiatry world Jun 21, 2023
Low Vitamin C in Psych Unit; MDMA Tested in Schizophrenia; Prison for Opioid Doc News and commentary from the psychiatry world Jun 14, 2023
LSD Win in Depression; Rethinking Placebo Effect; 1 in 4 Teens Misuse Stimulants News and commentary from the psychiatry world Apr 19, 2023
DBS for Schizophrenia; Top Psych Hospital Money Makers; Nature Prescriptions News and commentary from the psychiatry world Apr 05, 2023
Caplyta Success in Major Depression; Mental Illness and Aging; New PTSD Device OK'd News and commentary from the psychiatry world Mar 29, 2023
Some Antipsychotics Still Overused After In-Hospital Delirium Researchers call for more timely discontinuation of potentially inappropriate medications Feb 17, 2023
Oral Postpartum Depression Tx Heads to FDA; Shroom Microdosing; Autism and Motherese News and commentary from the psychiatry world Feb 08, 2023
FDA OKs Long-Acting Risperidone; TMS for Anxious Depression; CBT Bests Pharma News and commentary from the psychiatry world Jan 18, 2023
1 Psilocybin Dose for Depression; Add-On Schizophrenia Success; Genetic Suicidality News and commentary from the psychiatry world Jan 04, 2023
FDA OKs Vraylar for Depression; Schizophrenia Fingerprint? Fanapt Works in Bipolar News and commentary from the psychiatry world Dec 21, 2022
Clues on Why LAI Antipsychotics Are Underutilized in Schizophrenia Many clinicians say long-acting injectables should be reserved for patients with severe symptoms Nov 10, 2022
Eating Disorder Spike; $1M Fraud at Psych Clinic? Risperidone LAI Heads Back to FDA News and commentary from the psychiatry world Nov 09, 2022
First Admission Length for Schizophrenia Predicts Antipsychotic Choice Age also tied to use of long-acting injectable antipsychotic drugs Nov 07, 2022
Support Groups Improve Reproductive Health Awareness for High-Risk Psych Inpatients Women with psych disorders are 5 times more likely to have unplanned pregnancy, researcher says Nov 07, 2022
FDA Eases Clozapine REMS Recs; Auvelity Hits Shelves; Mass Murderers & Psychosis News and commentary from the psychiatry world Nov 02, 2022
Divide on When to Start Anti-Psychotic LAIs; Restraint Toll; Wilderness Tx Failures A roundup of noteworthy research from the American Psychiatric Nurses Association meeting Oct 24, 2022
Teen Suicide Trends; Kanye West's Bipolar Disorder; Schizophrenia and Dementia Risk News and commentary from the psychiatry world Oct 12, 2022
Rexulti Calms Alzheimer's Dementia-Related Agitation But atypical antipsychotic disappoints in borderline personality disorder Sep 19, 2022
Novel Combo for Schizophrenia Succeeds in Phase III Trial Xanomeline-trospium has potential to be first-in-class therapy for schizophrenia if approved Sep 19, 2022
KarXT Schizophrenia Win; CBD for Anxiety; No Nuplazid for Alzheimer's Psychosis News and commentary from the psychiatry world Aug 10, 2022
Promising New Depression Tx; Racially Skewed ADHD Dx; Effective Clozapine Monitoring News and commentary from the psychiatry world Jul 06, 2022
Electroconvulsive Therapy Linked to Manic Episode Response Vast majority of hospitalized patients responded to treatment Jun 23, 2022
Dual Therapy for Depression; Ties Between Illicit Drug Use and Youth Suicidality A round-up of noteworthy research from the American Psychiatric Association meeting May 26, 2022
Telepsychiatry Sessions Sufficient for Managing Schizophrenia "Clinics were very creative" during the pandemic, researcher says May 25, 2022
Add-On Vraylar Tied to Easing of Recurrent Depressive Symptoms Data show safety and efficacy of agent when paired with first-line antidepressants May 22, 2022
Cognitive Decline in Schizophrenia Begins as Early as Adolescence IQ scores fell by 16 points over adult life, smaller decline seen with other psychotic disorders May 18, 2022
FDA Clears TMS for OCD; Cerebral Pauses ADHD Scripts; Binge-Eating Drug Flops News and commentary from the psychiatry world May 11, 2022
Atypical Antipsychotics Linked to Lower Odds of COVID Study looked at psychiatric inpatients during first pandemic wave May 06, 2022
Dr. Fryer's Legacy; Zuranolone Starts Approval Process; Alzheimer's Vax Fast-Tracked News and commentary from the psychiatry world May 04, 2022
New Caplyta Doses OK'd; ECT Effective Against Suicide; Antidepressants Flop for QoL News and commentary from the psychiatry world Apr 27, 2022
Fetal Antipsychotic Exposure Cleared for Kids' Neurodevelopmental Disorders? Other maternal factors likely explain increased risk Mar 29, 2022
